BIOQUEST INTERNATIONAL INC
SB-2, EX-10.5, 2000-09-26
Previous: BIOQUEST INTERNATIONAL INC, SB-2, EX-10.4, 2000-09-26
Next: BIOQUEST INTERNATIONAL INC, SB-2, EX-10.6, 2000-09-26







                                                                    EXHIBIT 10.5













                          TECHNOLOGY LEASING AGREEMENT
                                     BETWEEN
                          BIOQUEST INTERNATIONAL, INC.
                                       AND
                             MAINSTREETIPO.COM, INC.










<PAGE>


                                LEASING AGREEMENT

     AGREEMENT   made  this  15th  day  of   September,   2000  by  and  between
MainStreetIPO.com  Inc.  ("MainStreet"),  with  principal  offices at 171 Church
Lane, North Brunswick, NJ 08902, and BioQuest International,  Inc. ("BioQuest"),
with principal  offices at 11217 Silverleaf  Drive,  Fairfax  Station,  Virginia
22039.

     WHEREAS,  MainStreet has designed a website known as  www.MainStreetIPO.com
(the  "Website"),  which  Website  was  created  for  the  purpose  of  enabling
corporations to publicly offer their  securities by means of posting  registered
prospectuses  on such  Website in order that  members of the public can bid in a
Dutch Auction for such securities; and

     WHEREAS,  BioQuest is desirous of leasing  the  technology  underlying  the
Website  ("the  Application  Services"),  utilizing  the generic  content of the
Website,  and leasing server space ("bandwidth") to enable BioQuest to conduct a
direct public offering of its Common Stock on a one time basis.

     WHEREAS,  MainStreet  is desirous of leasing  the  Application  Services to
BioQuest.

     NOW,  THEREFORE,  in  consideration  of the mutual  promises and  covenants
contained herein, the parties agree as follows:

     1. No Alterations or Changes of Non-Advertising Material.  BioQuest may not
alter or change any of the content  appearing  on the Website  without the prior
approval of MainStreet,  except to replace the name of "MainStreet IPO.com" with
the name  "BioQuestIPO.com"  and place  BioQuest's logo on the left hand side of
the Website.  BioQuest may not remove the graphical  depiction of the MainStreet
Bull which appears on the right hand side of the Website.  BioQuest also may not
change or alter in any way the  technology  of the  Website,  the Dutch  Auction
System  designed  for  the  Website  or any of the  technologies  or  interfaces
integrated  into  the  Dutch  Auction  System  without  the  prior  approval  of
MainStreet.

2.   Representations, Warranties and Covenants. MainStreet hereby represents and
     warrants to and agrees with BioQuest as follows:

     (a)  MainStreet is duly incorporated, validly existing and in good standing
          under the laws of the State of Delaware,  and has full corporate power
          and authority to execute,  deliver and perform this Leasing Agreement.
          This  Agreement  has been duly and validly  executed and  delivered by
          MainStreet  and  constitutes  the  legal  and  binding  obligation  of
          MainStreet enforceable against it in accordance with its terms;

     (b)  MainStreet  has  developed  and  designed  the  software  systems  and
          technology  for the  proper,  efficient  and lawful  operation  of the
          Website  to enable  issuers  to post  registered  offerings  under the
          Securities Act of 1933, including registration statements, preliminary
          prospectuses,  final prospectuses and to enable public users to submit
          bids for issuer's  securities being offered on the Website,  including
          the  transmission  and  recordation of all bidding  information and to
          establish and verify escrow accounts, and other related operations and
          procedures  necessary  for  issuers to offer their  securities  to the
          public  and to enable the public to bid and  acquire  such  securities
          ("MainStreet Technology");

     (c)  at all times the  Website  and the  MainStreet  Technology  will be in
          optimal functional condition,  including but not limited to sufficient
          facilities to handle high use volume  ("bandwidth")  and to accept and
          promptly  facilitate  the  bidding  process  for  BioQuest's  security
          offering  posted  on the  Website,  and  the  Website  and  MainStreet
          Technology  will at all times  during  the term of this  agreement  be
          maintained by MainStreet; provided, MainStreet does not insure against
          illegal or  unauthorized  site intrusion by person or persons  unknown
          whose  purpose is to interfere  with the  providing of services to the
          registered user;

     (d)  at all  times  the  Website  and  the  MainStreet  Technology  will be
          monitored  by  Interactica   Inc.  to  insure  proper  logging,   load
          balancing,  demographic recording, data back-up, storage and emergency
          response;

     (e)  the  software  has  been  properly   developed  and  the  Website  and
          MainStreet  Technology is fit for the purpose for which it is intended
          to be used;

     (f)  the  execution,   delivery  and  performance  by  MainStreet  of  this
          Agreement and the consummation by it of the transactions  contemplated
          hereby will not  conflict  with or violate any  existing  provision of
          law, rule or regulation, and such execution, delivery, performance and
          consummation will not, with or without the giving of notice, the lapse
          of time or both,  conflict with or violate (A) any order,  judgment or
          decree  applicable  to  MainStreet  or  binding  upon  its  assets  or
          properties,  (B)  any  provision  of the  by-laws  or  certificate  of
          incorporation of MainStreet,  or (C) any agreement or other instrument
          applicable to MainStreet or binding upon its assets or properties;

     (g)  it is the sole and  exclusive  owner of or otherwise  has the right to
          use and license all materials, methodologies and MainStreet Technology
          used in connection with the Website, and the use and licensing of such
          materials, methodologies and MainStreet Technology do not and will not
          (A) breach,  conflict with or constitute a default under any agreement
          or other  instrument  applicable  to  MainStreet  or binding  upon its
          assets or properties or (B) infringe upon any  trademark,  trade name,
          service  mark,  patent,  copyright or other  proprietary  right of any
          other person or entity;

     (h)  the  Website  and  the  MainStreet  Technology,  as  designed  and  as
          hereafter may be modified for BioQuest,  does not and will not violate
          any federal, state or local law or regulation;  neither MainStreet nor
          the  Website  is the  subject  of  any  disciplinary  proceeding;  and
          MainStreet  will comply with all applicable  federal,  state and local
          laws in the  maintenance  and  rental of its  Website  and  MainStreet
          Technology;

     (i)  there  is  no  pending  or,  to  the  best  knowledge  of  MainStreet,
          threatened claim, action or proceeding against MainStreet,  except for
          an informal  inquiry by the Securities  and Exchange  Commission as to
          possible broker-dealer registration requirements of MainStreet,  which
          has been  disclosed  to  BioQuest  , or any  affiliate  thereof,  with
          respect to the execution,  delivery or consummation of this Agreement,
          or with respect to the Website and the MainStreet Technology and their
          respective contents and, to the best knowledge of MainStreet, there is
          no basis for any such claim, action or proceeding; and

     (j)  it is, to the best of MainStreet's  knowledge,  in compliance with all
          federal and state privacy laws, is a member in good standing of the On
          Line Privacy Alliance,  and shall adhere to the information gathering,
          dissemination,  privacy  protection and other  practices  specified by
          such organization.

3.   Non-Assignability.  Neither  party may  assign or  delegate  its rights and
     obligations   under  this   Agreement,   except  that  MainStreet  may  use
     independent  contractors to provide  technological  support for the Website
     and MainStreet Technology.

4.   Procedures.  BioQuest  shall  not  do  anything  in  contravention  of  the
     procedures established by the MainStreet Technology regarding,  among other
     things,  registration of subscribers,  posting of  prospectuses,  the Dutch
     Auction process,  transfer agents or escrow agents, and shall adhere to the
     terms and conditions of this  Agreement  unless  otherwise  required by the
     Securities  and  Exchange  Commission  or  the  NASD  pursuant  to  federal
     securities laws or their Rules and Regulations or the various states' rules
     and regulations where such offering is registered.

5.   Term. The Term of this Agreement  shall be for a sufficient  period of time
     to enable  BioQuest to complete  its offering but in no event to exceed two
     hundred   seventy  (270)  days  after  the  effective  date  of  BioQuest's
     registration  statement  with the Securities  and Exchange  Commission.  If
     either  party  breaches the terms of this  Agreement  and fails to cure the
     breach within thirty (30) days after written notice of such breach from the
     other  party (or if the cure  cannot be  completed  in such thirty (30) day
     period,  the  breaching  party has failed to  initiate a cure  within  such
     thirty  (30) day period  and use  diligence  to  complete  the  cure),  the
     non-breaching  party may terminate  this  Agreement  upon fifteen (15) days
     written  notice to the other party by regular mail or facsimile sent to the
     address set forth above.

6.   No Acquisition of License,  Ownership or Rights.  All systems and processes
     developed by MainStreet and the MainStreet  Technology  shall be and remain
     the  exclusive  property  of  MainStreet.  All of the  systems  and related
     business  data and  MainStreet  Technology  are  Confidential  Information,
     except for that information which is generally  available to the public, is
     already or becomes  available to BioQuest on a  non-confidential  basis, or
     has been, is now, or later  independently  developed by BioQuest . BioQuest
     understands  and agrees  that,  notwithstanding  this  Agreement,  it shall
     acquire no other rights or licenses to any of the Confidential Information.

7.   Consideration.  In  consideration  for  MainStreet  leasing  the Website to
     BioQuest for a one time use which lease includes the Application  Services,
     MainStreet  shall receive a fee  consisting of $50,000  payable (i) $25,000
     upon BioQuest's execution of this Agreement with the balance of $25,000 due
     within ten (10) days after  BioQuest  ceases  using the  Website,  and (ii)
     warrants equal to one percent (1%) of the total shares of stock sold during
     the direct public  offering  exercisable  into the same number of shares of
     BioQuest  Common  Stock  at an  exercise  price of $1.00  per  share.  Said
     warrants to expire five (5) years from the date of this  Agreement.  In the
     event the  BioQuest  offering  is  unsuccessful  for any  reason,  then the
     compensation  reflected by the warrants  shall be adjusted as may be agreed
     upon by the parties.

8.   Indemnification.  MainStreet agrees to indemnify and hold harmless BioQuest
     and any person who controls  BioQuest  against any and all losses,  claims,
     damages  or  liabilities,  joint  or  several,  to  which  BioQuest  or any
     controlling  person may become  subject,  insofar as such  losses,  claims,
     damages or liabilities (or actions in respect  thereof) arise out of or are
     based  upon  any  technological  failures  of the  Website  and  MainStreet
     Technology,  other than illegal or unauthorized site intrusion by person or
     persons  unknown  whose  purpose  is to  interfere  with the  providing  of
     services to the then registered user, provided such illegal or unauthorized
     site  intrusion  is not due to the lack of proper  security  provided by or
     other negligence of MainStreet or the MainStreet  Technology.  In no event,
     shall  MainStreet  be liable for more than the fee paid by BioQuest,  which
     shall include the return of the warrants.

9.   Sole Agreement.  This Agreement,  together with all exhibits and schedules,
     constitutes the entire agreement of the parties with respect to the sale of
     the Website by MainStreet.

10.  Notices and Addresses.  All notices or other  communications  given or made
     under  this  Agreement  shall be in  writing  and  shall be (a)  personally
     delivered,  (b) sent by certified mail, return receipt  requested,  postage
     prepaid or by  reputable  overnight  courier  providing  a receipt  against
     delivery, or (c) sent by telecopy or facsimile transmission,  provided that
     a copy thereof is concurrently  delivered or sent in accordance with clause
     (a) or (b) above. Such notices or other  communications  shall be delivered
     or sent to:

                  to:               MainStreet IPO.com Inc.
                                    171 Church Lane
                                    North Brunswick, NJ 08902
                                    Attn: Joseph M. Salvani, Ch. of the Bd.

                  copy to:          Richard J. Blumberg, Esq.
                                    McLaughlin & Stern, LLP
                                    260 Madison Avenue
                                    New York, NY 10016

                  to:               BioQuest International, Inc.
                                    11271 Silverleaf Drive
                                    Fairfax Station, Virginia  22039

                  Copy to:          Carl Duncan, Esq.
                                    C/o Duncan, Blum & Associates.
                                    5718 Tanglewood Drive
                                    Bethesda, Maryland  20817

                                    Raymond J. Stewart, Esq.
                                    1350 Eye Street, N.W.
                                    Suite 200
                                    Washington, D.C.  20005

or such  other  address  as any  party  may  specify  in a notice  delivered  in
accordance with this Section 10.

11.  Applicable  Law.  This  Agreement  shall be  governed by and  construed  in
     accordance with the laws of the State of New York.

12.  Waiver.  No waiver of any breach or  condition of this  Agreement  shall be
     effective  unless in  writing  and  signed  by the  party (s)  sought to be
     charged therewith, and a waiver in one instance shall not be deemed to be a
     waiver of any other  subsequent  breach or  condition,  whether  of like or
     different nature.

13.  Use of Certain Terms.  Any  definitions  apply equally to both the singular
     and the plural;  any pronoun  shall  include the  corresponding  masculine,
     feminine and neuter; the words "include" and "including" shall be deemed to
     be followed by the phrase "without limitation";  and the terms "hereof" and
     "herein" shall refer to the particular  agreement or document in which such
     term appears.

14.  Captions.  Article  titles or  captions  contained  in this  Agreement  are
     inserted  only as a matter of  convenience  and as reference  and in no way
     define, limit, extend or describe the scope of this Agreement or the intent
     of any of the provisions hereof.

15.  Counterparts.  This  Agreement may be executed in one or more  counterparts
     and each of such counterparts  shall, for all purposes,  be deemed to be an
     original,  but all of the  counterparts  shall  constitute one and the same
     instrument,  and this Agreement shall be deemed effective on the date it is
     executed by the parties hereto.

16.  Binding.  This Agreement and all of its provisions  shall be binding on and
     inure  to  the  benefit  of the  successors  of the  parties.  None  of the
     provisions  of this  Agreement is intended to be, nor shall the  provisions
     construed  to be, for the  benefit  of any third  party.  Whenever  in this
     Agreement  reference is made to a party,  such reference shall be deemed to
     include a reference to the legal  representatives  and  successors  of such
     party.

17.  Severability.  If any of this Agreement or the applications  thereof to any
     person or party or  circumstances  shall be invalid or unenforceable to any
     extent,  the  remainder  of  this  Agreement  and the  application  of such
     provisions  to other  persons  or  parties  or  circumstances  shall not be
     affected  thereby and shall be enforced to the greatest extent permitted by
     law.

18.  Additional  Remedies.  The rights and remedies of any party hereunder shall
     not be  mutually  exclusive,  i.e.,  the  exercise  of one or  more  of the
     provisions  hereof shall not  preclude the exercise of any other  provision
     hereof.   The  respective   rights  and  obligations   hereunder  shall  be
     enforceable by specific performance,  injunction or other equitable remedy,
     but nothing herein  contained is intended to, nor shall it, limit or affect
     any other rights in equity or any rights at law or by statute or otherwise.

     IN WITNESS WHEREOF,  the parties have executed this Agreement as of the day
and year first above mentioned. MAINSTREETIPO.COM, INC.

                                          By: /s/ Joseph M. Salvani
                                          -------------------------
                                          JOSEPH M. SALVANI, Chairman
                                          of the Board, Chief Executive Officer
                                          and President

                                          BIOQUEST INTERNATIONAL, INC.

                                          By: /s/Peter J. Ewens
                                          ---------------------
                                          PETER J. EWENS, Chairman of the Board,
                                          Chief Executive Officer and President











© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission